Professor and Vice Chairman.

Dr. Steven K viagra-levitra-and-cialis.html . Libutti, Professor and Vice Chairman, Department of Surgery and Director of the Montefiore-Einstein Center for Cancers Care and Albert Einstein University of Medicine in New York City, will serve mainly because Principal Investigator for the scholarly study. Celsion Corporation first began studying ThermoDox in combination with RFA for liver metastases in a Stage I safety study of 24-patients, 15 of which experienced liver metastases from 9 main sites, including CRLM, stated Michael Tardugno, President and CEO of Celsion. The safety experience and dosage response relationship we witnessed in the Phase I study was obvious in both main and metastatic tumors. Continue reading